|
|
New Inhibitor Targeting Signal Transducer and Activator of Transcription 5 (STAT5) Signaling in Myeloid Leukemias
Ludovic Juen
,
Marie Brachet-Botineau
,
Cecile Parmenon
,
Jerome Bourgeais
,
Olivier Herault
,
et al.
Article dans une revue
hal-02411721v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Synthesis, biological evaluation and molecular modeling of a novel series of 7-azaindole based tri-heterocyclic compounds as potent CDK2/Cyclin E inhibitors
Christine Baltus
,
Radek Jorda
,
Christophe Marot
,
Karel Berka
,
Václav Bazgier
,
et al.
Article dans une revue
hal-02907101v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Rhodium-Catalyzed 1,4-Addition of Arylboronic Acids to 3-Benzylidene-1H-pyrrolo[2,3-b]pyridin-2(3H)-one Derivatives
Cécile Croix
,
Gildas Prié
,
Charlotte Chaulet
,
Marie-Claude Viaud-Massuard
Article dans une revue
hal-02903786v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers
Marie Brachet-Botineau
,
Marion Polomski
,
Heidi Neubauer
,
Ludovic Juen
,
Damien Hédou
,
et al.
Article dans une revue
hal-02459040v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
A Novel Inhibitor of STAT5 Signaling Overcomes Chemotherapy Resistance in Myeloid Leukemia Cells
Marie Brachet-Botineau
,
Margaux Deynoux
,
Nicolas Vallet
,
Marion Polomski
,
Ludovic Juen
,
et al.
Article dans une revue
hal-02423555v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
VAS3947 Induces UPR-Mediated Apoptosis through Cysteine Thiol Alkylation in AML Cell Lines
Maya El Dor
,
Hassan Dakik
,
Marion Polomski
,
Eloi Haudebourg
,
Marie Brachet
,
et al.
Article dans une revue
hal-03003770v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Inhibitors Targeting STAT5 Signaling in Myeloid Leukemias: New Tetrahydroquinoline Derivatives with Improved Antileukemic Potential
Marion Polomski
,
Marie Brachet-Botineau
,
Ludovic Juen
,
Marie-Claude Viaud-Massuard
,
Fabrice Gouilleux
,
et al.
Article dans une revue
hal-03047849v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|